WeightWatchers CEO Sima Sistani abruptly stepped down Friday after a two-year stint that included a controversial embrace of weight-loss drugs like Ozempic and Wegovy. Sistani pushed the 61-year ...

WeightWatchers' CEO of roughly two years, Sima Sistani, is out. She helped push the company into the white-hot weight-loss ...

Shares of personal wellness company WeightWatchers (NASDAQ:WW) jumped 54.1% in the morning session on continued positive ...

In response to rising demand for weight loss medications, WeightWatchers has launched a low-cost alternative to ...

Shares of WW International, better known as WeightWatchers, soared Tuesday after it said it is offering copycat weight-loss ...

For a business that now sees itself as being all about wellness and not just shedding pounds, the company formerly known as Weight Watchers looks like it has been on a crash diet. In the second ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

WeightWatchers (WW International) (NASDAQ:WW) stock is trading higher on Wednesday, with a session volume strong at 31.45 ...

WeightWatchers CEO Sima Sistani, who pushed the company into embracing weight-loss drugs, is leaving the position after a two-and-a-half year stint. Under Sistani, the 61-year-old company bought a ...

In addition to availability, the cost of weight loss drugs like Wegovy and Zepbound is a major barrier preventing many ...

WW International (NASDAQ:WW), more commonly known as WeightWatchers, will now offer compounded semaglutide to its ...